Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder
| Status: | Completed |
|---|---|
| Conditions: | Psychiatric, Eating Disorder |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 10/21/2012 |
| Start Date: | January 2010 |
| End Date: | October 2012 |
| Contact: | Anna Guerdjikova, PhD,MSW |
| Email: | anna.guerdjikova@lindnercenter.org |
| Phone: | 513-536-0721 |
Lisdexamfetamine in Binge Eating Disorder of Moderate or Greater Severity
The specific aim of this study is to examine the efficacy and safety of lisdexamfetamine
compared with placebo in outpatients with binge eating disorder
Inclusion Criteria:
- Patients will meet DSM-IV criteria for BED for at least the last 6 months
Exclusion Criteria:
- Women who are pregnant or lactating and women of childbearing potential who are not
taking adequate contraceptive measures. If there is a possibility a female subject
might be pregnant, a pregnancy test will be performed. (All women of childbearing
potential will have a negative pregnancy test before entering the study.)
- Subjects who are displaying clinically significant suicidality or homicidality.
- A current or recent (within 6 months of the start of study medication) DSM-IV
diagnosis of substance abuse or dependence
We found this trial at
1
site
